Clinical Trials

Find trials by condition, location & phase

Drug Monographs

Browse drug monographs and information

Explore organizations and their profiles

Latest updates on trials and healthcare

Approved products by global authorities

AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

NMPA Approval

Apatinib Mesylate Tablets

Approval Number

国药准字H20140104

Company江苏恒瑞医药股份有限公司

Registration Date

September 30, 2019

Drug Information

Generic Name

甲磺酸阿帕替尼片

Trade Name

艾坦

Brand Name

泰舒达

Dosage Form

片剂

Strength

0.375g(以阿帕替尼计)

Drug Type

化学药品

Registration Date

September 30, 2019

Company Information

Applicant Company

Company Name江苏恒瑞医药股份有限公司

Company Address

连云港经济技术开发区黄河路38号

Manufacturing Company

Company Name江苏恒瑞医药股份有限公司

Company Address

连云港经济技术开发区临港产业区东晋路

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy